home / stock / gmtx / gmtx message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: GMTX 28% v1,4M c2.01 f43,2M H2.03 LOD=ML1.25 | znewcar1 | investorshangout | 08/10/2022 9:44:39 PM |
Finally moving up again | adamski | investorshub | 12/30/2021 6:52:46 PM |
$22 upgrade is still on! | Antipro | investorshub | 12/21/2021 4:07:52 PM |
znewcar1: GMTX 23% v58,2M c2.99 f43,1M preMH3.67 S2.84 | znewcar1 | investorshangout | 12/15/2021 9:39:56 PM |
end of day move coming...bought 1000 shares at | adamski | investorshub | 12/15/2021 8:15:39 PM |
don't know...but all i can see is that | adamski | investorshub | 12/15/2021 7:49:59 PM |
Is it pure manipulation ? | mik1234 | investorshub | 12/15/2021 7:37:00 PM |
22 dollars is far away | adamski | investorshub | 12/15/2021 4:22:37 PM |
GMTX https://finance.yahoo.com/news/type-shareholders-own-most-number-120305954.html | TheFinalCD | investorshub | 12/15/2021 1:58:23 PM |
https://ih.advfn.com/stock-market/NASDAQ/gemini-therapeutics-GMTX/stock-news/868 | TheFinalCD | investorshub | 12/15/2021 1:22:27 PM |
$GMTX is obviously going to be a news | oxnous | investorshub | 07/10/2021 7:16:02 PM |
A high volume close over 6.75 would confirm, imo | oxnous | investorshub | 07/01/2021 12:00:28 AM |
Pretty decent volume today... this might be the bottom | aang | investorshub | 06/25/2021 5:16:25 PM |
Best to wait for a base build here | oxnous | investorshub | 06/24/2021 5:08:23 PM |
Gemini Therapeutics Announces Initial Data From Its Ongoing | oxnous | investorshub | 06/23/2021 8:23:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Gemini Therapeutics Inc. Company Name:
GMTX Stock Symbol:
NASDAQ Market:
Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic Protoporphyria PR Newswire WATERTOWN, Mass. , Dec. 27, 2022 /PRNewswire/ -- Disc Medicine, Inc. ("Disc"), a clinical-stage biopharmaceutical company focused on t...
Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP) PR Newswire AURORA study designed to evaluate bitopertin as a potential disease-modifying treatment for adults with EPP in the United States ...